Adhesion Barrier Market Size, Share & Analysis Report, 2024-2033
The global adhesion barrier market size was exhibited at USD 859.97 million in 2023 and is projected to hit around USD 1,772.43 million by 2033, growing at a CAGR of 7.5% during the forecast period 2024 to 2033.
Key Takeaways:
Adhesion Barrier Market Report Scope
| Report Coverage | Details |
| Market Size in 2024 | USD 924.47 Million |
| Market Size by 2033 | USD 1,772.43 Million |
| Growth Rate From 2024 to 2033 | CAGR of 7.5% |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Segments Covered | Product, Formulation, Application, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
| Key Companies Profiled | Sanofi S.A.; Becton Dickinson and Company; Baxter International, Inc.; Johnson & Johnson; Anika Therapeutic, Inc.; FzioMed, Inc; Mast Biosurgery, Inc.; Innocoll Holdings PLC; Atrium Medical Corporation (A part of Getinge Group). |
The key drivers of the market are the rising geriatric population coupled with the increasing number of surgical procedures. The surging frequency of invasive surgeries with a high risk of postoperative complications is anticipated to trigger market growth. However, with the rising risk of post-operation adhesion, the market is still witnessing barrier in terms of accessibility, lack of health education, and lack of awareness about the importance of treatment.
The adhesion barrier market is expected to see significant growth due to a few key factors. The improvement in healthcare infrastructure and the increasing availability of trauma care centers will drive the market forward. Additionally, the growing incidence of sports-related injuries is also expected to contribute to the growth of the market. Recent data from Stanford Children's Health shows that out of the approximately 30 million children who participate in some form of sports, over 10% experience injuries each year.
Also, the British Heart Foundation estimates that 32,938 completed heart surgeries and other heart procedures were carried out in England in just the month of October 2021. The rising frequency of operations and surgeries is anticipated to increase demand for adhesion barrier, further boosting market expansion. Adhesion barrier are frequently used after surgeries to lessen scars and avoid adhesions.
The adhesion barrier market is seeing growth due to several factors. Rising healthcare expenditure, along with increased FDA approval for various adhesion barrier products, is contributing to the market's expansion. For instance, Ethicon, Inc., a subsidiary of Johnson & Johnson, received FDA clearance for its VISTASEAL Fibrin Sealant (Human) product in November 2020. This product is designed to be used as an adjunct to hemostasis during surgery, to reduce the incidence of postoperative adhesions.
The FDA's approval of this product is just one example of how innovation and advancements in medical technology are driving growth in the advanced adhesion barrier market. As companies continue to develop new and improved products that can help prevent postoperative adhesions, we can expect to see increased demand for these products.
Segments Insights:
Product Insights
The Synthetic adhesion barrier accounted for the largest market size owing to high bioresorbable and biocompatibility. Synthetic adhesion barriers are cost-effective which is expected to increase sales of the segment. Moreover, the dominance of the segment is primarily attributed to the availability of commercial synthetic adhesion barrier. The segment is further divided into hyaluronic acid, regenerated cellulose, polyethylene glycol, and others. The hyaluronic acid segment dominates, owing to its capacity to attract and hold a vast amount of moisture.
Natural adhesion barrier segment also accounted for a considerable market share in 2023 and is expected to grow at a lucrative rate during the forecast period. The segment is further divided into collagen & protein, and fibrin. Collagen & protein segment held the largest market size owing to its benefits such as durability and safety. The fibrin segment is expected to grow at a rapid pace during the forecast period. The high growth rate of the fibrin segment is primarily attributed to the rising adoption of these products
Formulation Insights
The film/mesh segment dominated the market and accounted for the largest market share in 2023 and is expected to maintain its dominance during the forecast period. The large share of the segment is primarily attributed to its low cost and increasing use of film form adhesion in various surgeries. In addition, many clinical evidence are supporting the efficiency and safety of these forms of adhesion, thus, adding growth to the market growth.
Gel is expected to grow at the fastest rate during the forecast period. The high growth rate of the segment is primarily attributed to its advantages such as affordability, resorbability, easy application, and safety. Moreover, increasing usage of gels in various surgeries such as tendon, carpal tunnel, and joint or peripheral surgery is expected to expand its applications in upcoming years.
Application Insights
The cardiovascular surgeries segment dominated the market and is expected to grow at the fastest CAGR during the forecast period. The rising incidence of heart-related diseases and the increasing use of adhesion barrier in cardiovascular surgeries are the main drivers of growth in this segment of the advanced adhesion barrier market. A recent study published in the Annals of Medicine and Surgery in 2020 found that adhesion barriers are also beneficial in preventing the formation of peristomal adhesion. This highlights the versatility of adhesion barrier and their potential to improve patient outcomes in a variety of surgical procedures.
Gynecological surgery segment held the largest market share in 2023 and is expected to maintain its dominance during the forecast period. Market dominance is primarily attributed to a rising number of gynecologic laparoscopy procedures. Furthermore, increasing the adoption of gel form and film form in various gynecological procedures including endometriosis surgery, ovarian cystectomy, and ectopic pregnancy are boosting the market growth. Slow adoption of minimally invasive techniques in developing countries is expected to have a positive impact on the adoption of adhesion barrier. Minimally invasive surgeries require high priced equipment such as cameras and robot-assisted devices. Adoption of these devices is expected to be moderate in developing countries because of price sensitive customers.
Regional Insights
North America region dominated the adhesion barrier market and accounted for the largest revenue share in 2023. The market owing to the presence of major players such as Johnson & Johnson, Baxter International, Integra LifeSciences, Anika Therapeutics, and FzioMed. Increase in the prevalence of orthopedic conditions coupled with the high adoption of advanced treatment procedures is anticipated to fuel the market growth in the U.S.
Asia Pacific adhesive barrier market is expected to grow at a lucrative rate over the forecast period. The high growth rate in the region is primarily attributed to the rising geriatric population and increasing incidence of cardiac and neurosurgery which require surgical interventions. Moreover, rising private sector investment in healthcare and rapidly expanding medical tourism are expected to drive the growth of the adhesion barrier market in the region. Major countries such as India, China, and Japan are expected to contribute maximum growth to the region during the forecast period.
Some of the prominent players in the adhesion barrier market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global adhesion barrier market.
Adhesion Barrier Product
Adhesion Barrier Formulation
Adhesion Barrier Application
By Region
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. By product
1.1.2. By formulation
1.1.3. By application
1.1.4. Region Scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Formulation outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Adhesion Barrier Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rising geriatric population
3.4.1.2. Increasing number of sports related injury
3.4.1.3. Increasing prevalence of chronic disease
3.4.2. Market restraint analysis
3.4.2.1. Reluctance towards the usage of adhesion barrier among surgeons
3.4.2.2. Low awareness about post-surgical complication
3.4.3. Industry challenges
3.5. Adhesion Barrier Market Analysis Tools
3.5.1. Industry analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
Chapter 4. Adhesion Barrier Market by product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Synthetic adhesion barrier
4.1.1.1. Hyaluronic acid
4.1.1.2. Regenerated cellulose
4.1.1.3. Polyethylene glycol
4.1.1.4. Others
4.1.2. Synthetic adhesion barrier
4.1.2.1. Collagen & protein
4.1.2.2. Fibrin
4.2. Product Market Share, 2024 & 2033
4.3. Segment Dashboard
4.4. Global Adhesion Barrier Market by Component Outlook
4.4.1. Synthetic adhesion barrier
4.4.1.1. Synthetic adhesion market estimates and forecast, 2021 - 2033
4.4.1.2. Hyaluronic acid
4.4.1.2.1. Hyaluronic acid market estimates and forecast, 2021 - 2033
4.4.1.3. Regenerated cellulose
4.4.1.3.1. Regenerated cellulose acid market estimates and forecast, 2021 - 2033
4.4.1.4. Polyethylene glycol
4.4.1.4.1. Polyethylene glycol market estimates and forecast, 2021 - 2033
4.4.1.5. Others
4.4.1.5.1. Others glycol market estimates and forecast, 2021 - 2033
4.4.2. Synthetic adhesion barrier
4.4.2.1. Synthetic adhesion market estimates and forecast, 2021 - 2033
4.4.2.2. Collagen & protein
4.4.2.2.1. Collagen & Protein market estimates and forecast, 2021 - 2033
4.4.2.3. Fibrin
4.4.2.3.1. Fibrin market estimates and forecast, 2021 - 2033
Chapter 5. Adhesion Barrier Market: By Formulation Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Film/Mesh
5.1.2. Gel
5.1.3. Liquid
5.2 By Modality Market Share, 2019 & 2027
5.3 Segment Dashboard
5.4 Global Adhesion Barrier Market by Formulation Outlook
5.4.1 Film/Mesh
5.4.1.1 Film/Mesh market estimates and forecast, 2021 - 2033
5.4.2 Gel
5.4.2.1 Gel market estimates and forecast, 2021 - 2033
5.4.3 Liquid
5.4.3.1 Liquid market estimates and forecast, 2021 - 2033
Chapter 6. Adhesion Barrier Market: By Application Estimates & Trend Analysis
6.1 Definitions and Scope
6.1.1 Gynecological surgeries
6.1.2 Abdominal general surgeries
6.1.3 Orthopedic surgeries
6.1.4 Cardiovascular surgeries
6.1.5 Neurological surgeries
6.1.6 Urological surgeries
6.1.7 Others
6.2 Application Market Share, 2024 & 2033
6.3 Segment Dashboard
6.4 Global Adhesion Barrier Market by Application Outlook
6.4.1 Gynecological surgeries
6.4.1.1 Gynecological surgeries market estimates and forecast, 2021 - 2033
6.4.1.2 Gynecological surgeries market estimates and forecast, by product 2021 - 2033
6.4.1.2.1 Synthetic adhesion barrier
6.4.1.2.2 Natural adhesion barrier
6.4.1.3 Abdominal general surgeries market estimates and forecast, 2021 - 2033
6.4.1.4 Abdominal general surgeries market estimates and forecast, by product 2021 - 2033
6.4.1.4.1 Synthetic adhesion barrier
6.4.1.4.2 Natural adhesion barrier
6.4.1.5 Orthopedic surgeries market estimates and forecast, 2021 - 2033
6.4.1.6 Orthopedic general surgeries market estimates and forecast, by product 2021 - 2033
6.4.1.6.1 Synthetic adhesion barrier
6.4.1.6.2 Natural adhesion barrier
6.4.1.7 Cardiovascular surgeries market estimates and forecast, 2021 - 2033
6.4.1.8 Cardiovascular general surgeries market estimates and forecast, by product 2021 - 2033
6.4.1.8.1 Synthetic adhesion barrier
6.4.1.8.2 Natural adhesion barrier
6.4.1.9 Neurological surgeries market estimates and forecast, 2021 - 2033
6.4.1.10 Neurological surgeries market estimates and forecast, by product 2021 - 2033
6.4.1.10.1 Synthetic adhesion barrier
6.4.1.10.2 Natural adhesion barrier
6.4.1.11 Urological surgeries market estimates and forecast, 2021 - 2033
6.4.1.12 Urological surgeries market estimates and forecast, by product 2021 - 2033
6.4.1.12.1 Synthetic adhesion barrier
6.4.1.12.2 Natural adhesion barrier
6.4.1.13 Other surgeries market estimates and forecast, 2021 - 2033
6.4.1.14 Other surgeries market estimates and forecast, by product 2021 - 2033
6.4.1.14.1 Synthetic adhesion barrier
6.4.1.14.2 Natural adhesion barrier
Chapter 7 Adhesion Barrier Market: Regional Estimates & Trend Analysis
7.1 Regional Market Share Analysis, 2024 & 2033
7.1.1 Regional Market Dashboard
7.2 Regional Market Share and Leading Players, 2024
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East and Africa
7.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Latin America
7.3.5 Middle East and Africa
7.4 Market Size, & Forecasts, Volume and Trend Analysis, 2023 to 2030:
7.5 North America
7.5.1 Market estimates and forecast, 2021 - 2033
7.5.2 U.S.
7.5.2.1 U.S. market estimates and forecast, 2021 - 2033
7.5.3 Canada
7.5.3.1 Canada market estimates and forecast, 2021 - 2033
7.6 Europe
7.6.1 Market estimates and forecast, 2021 - 2033
7.6.2 U.K.
7.6.2.1 U.K. market estimates and forecast, 2021 - 2033
7.6.3 Germany
7.6.3.1 Germany market estimates and forecast, 2021 - 2033
7.6.4 France
7.6.4.1 France market estimates and forecast, 2021 - 2033
7.6.5 Italy
7.6.5.1 Italy market estimates and forecast, 2021 - 2033
7.6.6 Spain
7.6.6.1 Spain market estimates and forecast, 2021 - 2033
7.6.7 Switzerland
7.6.7.1 Switzerland market estimates and forecast, 2021 - 2033
7.6.8 Russia
7.6.8.1 Russia market estimates and forecast, 2021 - 2033
7.6.9 Poland
7.6.9.1 Poland market estimates and forecast, 2021 - 2033
7.6.10 Netherland
7.6.10.1 Netherland market estimates and forecast, 2021 - 2033
7.6.11 Greece
7.6.11.1 Greece market estimates and forecast, 2021 - 2033
7.6.12 Sweden
7.6.12.1 Sweden market estimates and forecast, 2021 - 2033
7.6.13 Denmark
7.6.13.1 Denmark market estimates and forecast, 2021 - 2033
7.6.14 Norway
7.6.14.1 Norway market estimates and forecast, 2021 - 2033
7.7 Asia Pacific
7.7.1 Market estimates and forecast, 2021 - 2033
7.7.2 Japan
7.7.2.1 Japan market estimates and forecast, 2021 - 2033
7.7.3 China
7.7.3.1 China market estimates and forecast, 2021 - 2033
7.7.4 India
7.7.4.1 India market estimates and forecast, 2021 - 2033
7.7.5 Australia
7.7.5.1 Australia market estimates and forecast, 2021 - 2033
7.7.6 South Korea
7.7.6.1 South Korea market estimates and forecast, 2021 - 2033
7.7.7 Vietnam
7.7.7.1 Vietnam market estimates and forecast, 2021 - 2033
7.7.8 New Zealand
7.7.8.1 New Zealand market estimates and forecast, 2021 - 2033
7.7.9 Malaysia
7.7.9.1 Malaysia market estimates and forecast, 2021 - 2033
7.7.10 Indonesia
7.7.10.1 Indonesia market estimates and forecast, 2021 - 2033
7.7.11 Hong Kong
7.7.11.1 Hong Kong market estimates and forecast, 2021 - 2033
7.7.12 Singapore
7.7.12.1 Singapore market estimates and forecast, 2021 - 2033
7.7.13 Taiwan
7.7.13.1 Taiwan market estimates and forecast, 2021 - 2033
7.7.14 Thailand
7.7.14.1 Thailand market estimates and forecast, 2021 - 2033
7.8 Latin America
7.8.1 Market estimates and forecast, 2021 - 2033
7.8.2 Brazil
7.8.2.1 Brazil market estimates and forecast, 2021 - 2033
7.8.3 Mexico
7.8.3.1 Mexico market estimates and forecast, 2021 - 2033
7.8.4 Colombia
7.8.4.1 Colombia market estimates and forecast, 2021 - 2033
7.8.5 Argentina
7.8.5.1 Argentina market estimates and forecast, 2021 - 2033
7.8.6 Chile
7.8.6.1 Chile market estimates and forecast, 2021 - 2033
7.9 Middle East & Africa
7.9.1 Market estimates and forecast, 2021 - 2033
7.9.2 South Africa
7.9.2.1 South Africa market estimates and forecast, 2021 - 2033
7.9.3 Saudi Arabia
7.9.3.1 Saudi Arabia market estimates and forecast, 2021 - 2033
7.9.4 Egypt
7.9.4.1 Egypt market estimates and forecast, 2021 - 2033
7.9.5 Oman
7.9.5.1 Oman market estimates and forecast, 2021 - 2033
7.9.6 UAE
7.9.6.1 UAE market estimates and forecast, 2021 - 2033
7.9.7 Kuwait
7.9.7.1 UAE market estimates and forecast, 2021 - 2033
Chapter 8 Competitive Landscape
8.1 Recent Developments & Impact Analysis, By Key Market Participants
8.2 Company/Competition Categorization
8.2.1 Innovators
8.3 Vendor Landscape
8.3.1 List of key distributors and channel partners
8.3.2 Key customers
8.3.3 Key company market share analysis, 2022
8.3.4 Medtronic Plc
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Procedure benchmarking
8.3.4.4 Strategic initiatives
8.3.5 Johnson & Johnson
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Procedure benchmarking
8.3.5.4 Strategic initiatives
8.3.6 Sanofi
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Procedure benchmarking
8.3.6.4 Strategic initiatives
8.3.7 Baxter International Inc.,
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Procedure benchmarking
8.3.7.4 Strategic initiatives
8.3.8 Becton Dickinson and Company
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Procedure benchmarking
8.3.8.4 Strategic initiatives
8.3.9 Integra LifeSciences Holdings Corporation
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Procedure benchmarking
8.3.9.4 Strategic initiatives
8.3.10 Anika Therapeutics
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Procedure benchmarking
8.3.10.4 Strategic initiatives
8.3.11 Atrium Medical Corporation
8.3.11.1 Company overview
8.3.11.2 Financial performance
8.3.11.3 Procedure benchmarking
8.3.11.4 Strategic initiatives
8.3.12 FzioMed
8.3.12.1 Company overview
8.3.12.2 Financial performance
8.3.12.3 Procedure benchmarking
8.3.12.4 Strategic initiatives
8.3.13 Mast Biosurgery
8.3.13.1 Company overview
8.3.13.2 Financial performance
8.3.13.3 Procedure benchmarking
8.3.13.4 Strategic initiatives
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers